Please use this identifier to cite or link to this item:
|Title:||Assessing and accelerating new product introductions in a pharmaceutical plant|
|Authors:||Karimi, I.A. |
|Keywords:||New product introduction|
|Source:||Karimi, I.A.,Sundaramoorthy, A. (2004). Assessing and accelerating new product introductions in a pharmaceutical plant. AIChE Annual Meeting, Conference Proceedings : 8625-8626. ScholarBank@NUS Repository.|
|Abstract:||A multi-period, continuous-time, mixed-integer linear programming model that addresses product introduction issues in pharmaceutical plants using multiple parallel production liens in campaign modes was discussed. The aim was to decide the optimal production levels of various intermediates and optimal supply amounts of various Als to maximize the overall gross profit for the plant. The disruptions that occur in the production of existing products when the new products enter the production phase were also analyzed. The time to market and the quick reap of the profits from the new products before their shortened life cycles are the keys to the success of such pharmaceutical companies.|
|Source Title:||AIChE Annual Meeting, Conference Proceedings|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 9, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.